Please login to the form below
anxiety
This page shows the latest anxiety news and features for those working in and with pharma, biotech and healthcare.
NHS bracing for 'no deal’ Brexit impact, including medicines
The reality is that medicines, medical supplies and devices are all part of a highly interdependent system – it would be wrong to cause unnecessary anxiety or alarm among patients, but we
Latest news
-
Alexion adds to pipeline rebuild with $855m Wilson buy
Alexion put to rest some of the anxiety about its ability to diversify beyond paroxysmal nocturnal haemoglobinuria (PNH) treatment Soliris (eculizumab) when it reported phase III data for follow-up ALXN1210,
-
NICE backs trial of online and mobile depression programme
The briefing is the first fruit of a programme NICE launched last year to assess the use of digital therapies, such as computer programmes or applications, to treat anxiety and depression.
-
UK biotech Vaccitech raises £20m for universal flu shot
In a week where Australian and Japanese flu strains are raising anxiety in the UK, one of the country’s biotech companies has just raised funding to progress a universal flu
-
Moving times
expressing their anxieties: ‘we are… concerned that our rights and freedoms, as legally guaranteed in the current hosting Member State and as enshrined in Union law, may be directly and adversely
-
Online therapy for dementia carers to be studied
Researchers are set to investigate online therapy for people that care for someone with dementia to see if it can help them cope with feelings of stress, anxiety or depression.
More from news
Approximately 1 fully matching, plus 140 partially matching documents found.
Latest Intelligence
-
The Patient Safety Challenge
There were anxieties about how reporting could affect their reputations and career prospects.
-
Finding the patient voice
This data provided the big picture about what motivates people to join clinical trials, their anxieties and their experiences. ... we should communicate with them, depending on their needs and anxieties.
-
Grünenthal's relentless pursuit of relief
The pursuit of pain relief is nowhere near over and many companies and institutions are chasing answers to reduce the impact of chronic pain and its corrosive byproducts: anxiety, fatigue, depression
-
Mining for results
And being on AWS certainly does help in that regard. it takes a good amount of their anxiety away,” he explains.
-
An effective commercial model for cancer care
as anxiety, energy and stress. ... Even when treatment is completed and no cancer remains, serious residual effects such as depression, anxiety and post-traumatic stress disorder impair patients' abilities to perform activities of daily living, limiting
More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.
Latest appointments
-
Dr Niall Murphy and Pierre Schwich join Pharnext
Prior to this, Dr Murphy served as a unit leader for a team of scientists collaborating on research in the areas of addition biology, Alzheimer's disease, anxiety, depression and neurotoxicity
-
Turing names Eliseo Salinas as head of R&D
Salinas has played a leading role in numerous programmes for a range of diseases and disorders, with specific focus on central nervous systems (CNS) condition such as depression and anxiety, schizophrenia,
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Virtual reality—a change for the better in medical education
References. Anderson PL, Price M, Edwards SM, et al. Virtual reality exposure therapy for social anxiety disorder: a randomized controlled trial. ... The effectiveness of virtual reality on reducing pain and anxiety in burn injury patients: a systematic
-
A safe place to talk about Crohn’s
Anxiety and embarrassment are a vicious circle for people with Crohn’ s disease.
-
No one is listening to you!
The secret is in breaking down barriers and overcoming their anxieties.
-
Mental health in the workplace
Managing mental health conditions (such as stress, anxiety, depression and obsessive– compulsive disorder) remains a challenge, despite the recent efforts of many companies to implement policies to support a healthy workforce.
-
Doctor doctor, where are all the men?
This understandable anxiety is preventing men from seeing a GP and potentially receiving a life-saving screening service.
More from PMHub
Approximately 0 fully matching, plus 18 partially matching documents found.
Featured jobs
-
Senior Account Manager
-
Competitive salary commensurate with experience
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Business Unit Head, Medical Communications, London
-
Excellent package
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
-
Client Services Director - Med Comms
-
Great salary and bebefits
- Senior Project Manager - Medical Writing
-
Great salary and bebefits
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
Subscribe to our email news alerts
- Communiqué Awards 2018: Photo Gallery - Communiqué Awards 2016
- GSK sells eczema and psoriasis drug to Dermavant for £250m
- Moving annual total (MAT)
- Roche keeps Venclexta train rolling with new leukaemia filing
- NHS England says yes to Roche's Hemlibra
- Daily Brief: Trump arrives in London, NICE says no to Darzalex, Pfizer backs down on prices
- Huntsworth buys Giant Creative Strategy
- Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator
- Brexit rebels win vote on European Medicines Agency alignment
- Data Visualisation
- The True Potential of Mobile Health Tech
- NHS England to Vertex: come clean on Orkambi offer
PMHub
Nobull Communications
Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...
Latest intelligence
- Developing advocacy in the pharmaceutical industry.
- The importance of advocacy programmes...
- GDPR and events. What does the pharma industry need to know?
- Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
Quick links
Infographics
